Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer Jun 2, 2024 08:00AM
Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers Jun 1, 2024 08:00AM
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update Feb 21, 2024 04:05PM
Gilead Sciences (GILD), Arcus (RCUS) Announce Amended Collaboration and $320M Equity Investment Jan 29, 2024 05:01PM
Gilead and Arcus Announce Amended Collaboration and Equity Investment Jan 29, 2024 05:00PM
View Older Stories

Dec 4, 2023 08:03AM Exelixis (EXEL), Arcus Biosciences (RCUS) Announce Clinical Trial Collaboration to Evaluate Zanzalintinib in Combination with AB521 in Patients with Advanced Renal Cell Carcinoma
Dec 4, 2023 08:00AM Exelixis and Arcus Biosciences Announce Clinical Trial Collaboration to Evaluate Zanzalintinib in Combination with AB521 in Patients with Advanced Renal Cell Carcinoma
Nov 7, 2023 04:01PM Arcus Biosciences Reports Third Quarter 2023 Financial Results and Provides a Pipeline Update
Oct 17, 2023 04:00PM Arcus Biosciences to Present Data from Ongoing EDGE-Gastric Study at ASCO Plenary and to Report Third-Quarter Financial Results on November 7
Aug 23, 2023 09:00AM Arcus Biosciences to Participate in Multiple Upcoming Investor Conferences
Aug 7, 2023 08:00AM Arcus Biosciences Reports Second-Quarter 2023 Financial Results and Provides a Pipeline Update
Jun 3, 2023 01:30PM Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer Study
May 30, 2023 04:00PM Arcus Biosciences to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
May 17, 2023 08:30AM Presentations at the 2023 ASCO Annual Meeting Highlight Arcus Biosciences’ Expanding Portfolio of Investigational Medicines and Late-Stage Studies Across Multiple Types of Cancer
May 15, 2023 08:30AM Gilead Sciences and Arcus Biosciences Expand Partnership to Include Research Programs in Inflammation
May 9, 2023 04:05PM Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update
Mar 2, 2023 04:00PM Arcus Biosciences to Participate in the Barclays Global Healthcare Conference
Feb 28, 2023 04:05PM Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update
Jan 24, 2023 04:05PM Arcus Biosciences Announces New Employment Inducement Grants
Jan 10, 2023 04:05PM Arcus Biosciences Announces New Employment Inducement Grants
Dec 23, 2022 08:00PM Arcus Biosciences Announces New Employment Inducement Grants
Dec 19, 2022 05:01PM Gilead (GILD) and Arcus (RCUS) Report Strong Interim Results of ARC-7 Study
Dec 19, 2022 05:00PM Anti-TIGIT Domvanalimab-Containing Study Arms Improve Progression-Free Survival Compared to Anti-PD1 Alone in Phase 2 Non-Small Cell Lung Cancer Study
Dec 19, 2022 05:00PM Anti-TIGIT Domvanalimab-Containing Study Arms Improve Progression-Free Survival Compared to Anti-PD1 Alone in Phase 2 Non-Small Cell Lung Cancer Study
Dec 9, 2022 04:05PM Arcus Biosciences Announces New Employment Inducement Grants
Nov 28, 2022 08:31AM Gilead (GILD) and Arcus Biosciences (RCUS) Announce Positive Update on Joint TIGIT Program From Interim Analysis of ARC-7 Study in Non-small Cell Lung Cancer
Nov 28, 2022 08:30AM Gilead and Arcus Biosciences Announce Positive Update on Joint TIGIT Program From Interim Analysis of ARC-7 Study in Non-Small Cell Lung Cancer
Nov 28, 2022 08:30AM Gilead and Arcus Biosciences Announce Positive Update on Joint TIGIT Program From Interim Analysis of ARC-7 Study in Non-small Cell Lung Cancer
Nov 24, 2022 04:05PM Arcus Biosciences Announces New Employment Inducement Grants
Nov 14, 2022 04:05PM Arcus Biosciences to Participate in the 5th Annual Evercore ISI HealthCONx Conference
Nov 9, 2022 04:05PM Arcus Biosciences Announces New Employment Inducement Grants
Nov 2, 2022 04:02PM Arcus Biosciences Reports Third Quarter 2022 Financial Results and Provides a Pipeline Update
Oct 25, 2022 04:05PM Arcus Biosciences Announces New Employment Inducement Grants
Oct 11, 2022 04:05PM Arcus Biosciences Announces New Employment Inducement Grants
Sep 26, 2022 04:05PM Arcus Biosciences Announces New Employment Inducement Grants
Sep 9, 2022 04:05PM Arcus Biosciences Announces New Employment Inducement Grants
Aug 24, 2022 04:05PM Arcus Biosciences to Participate in Two Upcoming Investor Conferences
Aug 24, 2022 04:05PM Arcus Biosciences Announces New Employment Inducement Grants
Aug 9, 2022 04:05PM Arcus Biosciences Announces New Employment Inducement Grants
Aug 8, 2022 04:06PM Arcus Biosciences (RCUS) Appoints Dimitry Nuyten as Chief Medical Officer
Aug 8, 2022 04:05PM Arcus Biosciences Appoints Dimitry Nuyten, M.D., Ph.D. as Chief Medical Officer
Aug 3, 2022 04:03PM Arcus Biosciences Reports Second Quarter 2022 Financial Results and Provides a Pipeline Update
Jul 27, 2022 04:01PM Arcus Biosciences to Participate in the 13th Annual Wedbush PacGrow Healthcare Conference
Jul 26, 2022 04:05PM Arcus Biosciences Announces New Employment Inducement Grants
Jul 11, 2022 04:10PM Arcus Biosciences Announces New Employment Inducement Grants
Jun 24, 2022 04:10PM Arcus Biosciences Announces New Employment Inducement Grants
Jun 9, 2022 04:10PM Arcus Biosciences Announces New Employment Inducement Grants
May 31, 2022 04:05PM Arcus Biosciences to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
May 24, 2022 04:10PM Arcus Biosciences Announces New Employment Inducement Grants
May 10, 2022 04:10PM Arcus Biosciences Announces New Employment Inducement Grants
May 9, 2022 04:03PM Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study
Apr 26, 2022 04:30PM Arcus Biosciences to Report First Quarter 2022 Financial Results and Pipeline Update
Apr 26, 2022 04:10PM Arcus Biosciences Announces New Employment Inducement Grants
Apr 11, 2022 04:10PM Arcus Biosciences Announces New Employment Inducement Grants
Apr 5, 2022 09:13AM Pre-Open Stock Movers 04/05: (RCUS) (TWTR) (EZPW) Higher; (XPOF) (CVNA) (FSLR) Lower (more...)
View Older Stories